Drug intelligence / Profile preview

RWQWRWQWR-Ahx-RRRRRRRR

Development stage
Preclinical
Lead developer
Universidad Nacional de Colombia
Modality
Peptides
01

Overview

RWQWRWQWR-Ahx-RRRRRRRR is a synthetic hybrid peptide designed for anticancer activity, specifically targeting cervical cancer. It consists of a palindromic core sequence (RWQWRWQWR) derived from bovine lactoferricin (LfcinB) linked via a 6-aminohexanoic acid (Ahx) spacer to an octa-arginine (RRRRRRRR) cell-penetrating peptide (CPP). The mechanism of action involves initial electrostatic interactions between the positively charged arginine residues and the negatively charged components of the cancer cell surface, followed by membrane disruption or internalization facilitated by the hydrophobic tryptophan residues. In vitro studies demonstrate significant cytotoxic activity against HeLa and Ca Ski cervical cancer cell lines, with a rapid effect observed within 2 hours. The peptide was developed by researchers at the Universidad Nacional de Colombia and Pontificia Universidad Javeriana as part of a strategy to enhance the selective cytotoxic effect of bioactive peptides against tumor cells.

Other names
RWQWRWQWR-Ahx-R8RWQWRWQWR-Ahx-R-8RWQWRWQWR-Ahx-R 8

Beyond the preview

Go deeper on RWQWRWQWR-Ahx-RRRRRRRR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RWQWRWQWR-Ahx-RRRRRRRR.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call